Cholesterol News and Research

RSS

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid.

Cholesterol expert offers simple resolutions and advice for staying heart healthy in New Year

Family physician and cholesterol expert Michael Cobble, M.D., has some simple resolutions and fun advice for staying heart healthy in the new year. Cobble is a board-certified clinical lipidologist (NLA), certified hypertension specialist (ASH), medical director of the private practice Canyons Medical Center in Sandy, Utah, and Chief Medical Officer at Atherotech, Inc., developer of the VAP Cholesterol Test.

29 Dec 2009

Nutrient-rich foods for weight loss

For the majority of Americans who are unhappy with their weight at any given moment, the New Year brings mixed emotions: the renewed resolution to shed pounds and the challenge of learning how to eat right to reach those goals.

29 Dec 2009

Masimo expands corporate headquarters

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced the expansion of its Irvine, California headquarters with the addition of an adjacent 32,000 sq. ft. building--the company's third building at its corporate campus. Expanding its corporate headquarters is a natural progression for Masimo, which continues to post double-digit growth increases.

28 Dec 2009

SemBioSys Genetics' Apo AI(Milano) program progress update

SemBioSys Genetics Inc. provided an update today on its progress on plant-produced Apo AI(Milano) in light of the Apo AI(Milano) license agreement between Pfizer Inc. and The Medicines Company, of Parsippany, New Jersey.

24 Dec 2009

Perspective of the future influences health decisions

When New Year's Eve rolls around and you're deciding whether to have another glass of champagne, your decision may be predicted by your perspective of the future.

24 Dec 2009

Calorie disclosure requirement in healthcare reform legislation ineffective and expensive, says VMI

A group representing some of the nation's most prominent vending companies today called on Congress to drop language that would require vending companies to disclose the caloric content of vended food and beverage products prior to the point of sale, Vend Marketing Institute (VMI) Executive Director Chris Stave announced today. The requirement is included in both the House and Senate versions of the healthcare reform legislation currently being debated in Congress, and would apply to any business which owns or operates 20 or more vending machines.

24 Dec 2009

Eli Lilly and Kowa Pharmaceuticals America to co-promote LIVALO in the U.S

Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.

24 Dec 2009

Union Bank and AHA announce new sponsorship agreement

Union Bank, N.A., and The American Heart Association (AHA) have announced a four-year agreement to promote the AHA’s Start! movement in Los Angeles, Orange, and San Diego counties.

24 Dec 2009

Cardiac marker POC test: A successful concept of point-of-care diagnostics

Cardiac marker POC tests are now widely used in hospitals and have emerged as a successful model of the concept of point-of-care diagnostics, according to a new report from Kalorama Information. The 2008 world market for POC cardiac enzymes and tests is estimated at $490 million, and growing at 12% a year for the past three years, according to "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," from healthcare market research publisher Kalorama Information.

24 Dec 2009

Merck discontinues MK-1903 niacin receptor agonist development program with Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. announced today Merck and Co., Inc.'s decision (through an affiliate) to discontinue development of MK-1903, an investigational niacin receptor agonist to treat atherosclerosis being developed under its research collaboration with Arena. Merck also informed Arena that the company will not continue the collaboration.

24 Dec 2009

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).

23 Dec 2009

Niacin may not be beneficial for type 2 diabetic patients

High-density lipoprotein (HDL), known as "good" cholesterol, isn't as protective for people with type 2 diabetes, according to research reported in Circulation: Journal of the American Heart Association.

22 Dec 2009

Schering and MSP Singapore sue Mylan over generic Vytorin ANDA

Mylan Inc. today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Schering Corporation and MSP Singapore Company in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg. This product is the generic version of Vytorin® Tablets, a cholesterol treatment.

22 Dec 2009

Interactive Health Partner expands fitness tracking capabilities with Garmin running and fitness devices

The Interactive Health Partner (www.InteractiveHealthPartner.com), developed by PCE Health & Fitness, recently expanded exercise logging and fitness tracking capabilities by integrating with Garmin running and fitness devices.

From Garmin 22 Dec 2009

Healthy Humans receives the 2009 Life Sciences Startup Company of the Year award

Healthy Humans (www.healthyhumans.com), an online wellness solutions company, received the 2009 Life Sciences Startup Company of the Year award from the Eastern Technology Council.

21 Dec 2009

Medica's clinic-based chronic care management program delivers promising results

Medica’s clinic-based chronic care management program with six clinic partners shows that focusing on care coordination is beginning to deliver promising results. A recent program evaluation reported that members participating in the clinical pilots had 1 percent more doctor visits and 3 percent more prescription fills than members with similar conditions seen in traditional clinic settings.

19 Dec 2009

CLIAWAIVED.COM expands its business into GPO market by signing the first major GPO

CLIAWAIVED.COM, Inc., the leading Internet-based, multi-line distributor of point-of-care CLIA Waived Diagnostic tests, medical products and physician office supplies, today announced the planned expansion of their business into the GPO (Group Purchasing Organization) market with the signing of their first major GPO, representing nearly 700 physician offices and 7000+ doctors.

19 Dec 2009

Jubilant Organosys announces new facility for Niacinamide and 3-Cyanopyridine

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, announced today that it is setting up Niacinamide and 3-Cyanopyridine plant of 10,000 TPA each, expected to be ready by end of 2010.

18 Dec 2009

Smart Balance announces $25 million stock repurchase program

Smart Balance, Inc. announced today that its board of directors has authorized a two-year stock repurchase program of up to $25 million, to begin in 2010.

17 Dec 2009

Pistachios can decrease inflammation and cardiovascular disease

New research published online, December 10, 2009 indicates that bioactive compounds in pistachios, and molecules present in pistachios, have anti-inflammatory properties.

17 Dec 2009